Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Belanger

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal - American Health Care Association|April 10, 1985
Rights of association and communicationP M Belanger
Journal of Clinical Pharmacology|October 1, 1982
Pharmacokinetics of nalidixic acid in old and young volunteersG Barbeau, P M Belanger
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1978
The disposition of phentermine and its N-oxidized metabolic products in the rabbitA H Beckett, P M Belanger
Biochemical Pharmacology|August 15, 1977
The in vitro metabolism of mephentermineA H Beckett, P M Belanger
Journal of Pharmaceutical Sciences|October 1, 1989
Simultaneous determinations of tolbutamide and its hydroxy and carboxy metabolites in serum and urine: application to pharmacokinetic studies of tolbutamide in the ratS St-Hilaire, P M Belanger
The Journal of Pharmacy and Pharmacology|July 1, 1975
Metabolic incorporation of oxygen into primary and secondary aliphatic amines and the consequences in carbon-nitrogen bond cleavageA H Beckett, P M Belanger
Journal of Clinical Pharmacology|November 1, 1983
Inhibitory effect of isoniazid on antipyrine clearance in manO Grech-Belanger, P M Belanger, J Lachance
Journal D'Urologie Et De Nephrologie|January 1, 1974
[Acute and chronic prolonged ureteral obstruction]I Rovinescu, P M Belanger, B Fleurent, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Temporal variations in the pharmacokinetics of isoniazid and N-acetylisoniazid in ratsP M Belanger, M Lalande, F M Dore, et al.
Toxicology|March 1, 1983
Temporal variations in chloroform-induced hepatotoxicity in ratsJ G Lavigne, P M Belanger, F Dore, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal - American Health Care Association|April 10, 1985
Rights of association and communicationP M Belanger
Journal of Clinical Pharmacology|October 1, 1982
Pharmacokinetics of nalidixic acid in old and young volunteersG Barbeau, P M Belanger
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1978
The disposition of phentermine and its N-oxidized metabolic products in the rabbitA H Beckett, P M Belanger
Biochemical Pharmacology|August 15, 1977
The in vitro metabolism of mephentermineA H Beckett, P M Belanger
Journal of Pharmaceutical Sciences|October 1, 1989
Simultaneous determinations of tolbutamide and its hydroxy and carboxy metabolites in serum and urine: application to pharmacokinetic studies of tolbutamide in the ratS St-Hilaire, P M Belanger
The Journal of Pharmacy and Pharmacology|July 1, 1975
Metabolic incorporation of oxygen into primary and secondary aliphatic amines and the consequences in carbon-nitrogen bond cleavageA H Beckett, P M Belanger
Journal of Clinical Pharmacology|November 1, 1983
Inhibitory effect of isoniazid on antipyrine clearance in manO Grech-Belanger, P M Belanger, J Lachance
Journal D'Urologie Et De Nephrologie|January 1, 1974
[Acute and chronic prolonged ureteral obstruction]I Rovinescu, P M Belanger, B Fleurent, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Temporal variations in the pharmacokinetics of isoniazid and N-acetylisoniazid in ratsP M Belanger, M Lalande, F M Dore, et al.
Toxicology|March 1, 1983
Temporal variations in chloroform-induced hepatotoxicity in ratsJ G Lavigne, P M Belanger, F Dore, et al.
Pageof 1